Bethesda, MD, United States of America

Chi-Ming Liang

USPTO Granted Patents = 2 


 

Average Co-Inventor Count = 3.4

ph-index = 2

Forward Citations = 24(Granted Patents)


Company Filing History:


Years Active: 1999-2001

Loading Chart...
Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: Chi-Ming Liang: Innovator in Medical Research

Introduction

Chi-Ming Liang is a notable inventor based in Bethesda, MD (US). He has made significant contributions to the field of medical research, particularly in the development of monoclonal antibodies and methods for treating vascular leakage syndrome.

Latest Patents

Chi-Ming Liang holds 2 patents. His latest patents include "Monoclonal antibodies specific for human thymidylate synthase," which relates to monoclonal antibodies that are specific for the protein thymidylate synthase. This invention also encompasses methods of detection and diagnostic kits to test for the presence of thymidylate synthase, as well as the use of these antibodies in determining the presence of colon carcinoma cells. Another significant patent is for the "Treatment of vascular leakage and related syndrome such as septic shock." This patent describes a method for identifying patients at risk of developing vascular leakage syndrome and systemic inflammatory response syndrome (SIRS) by determining serum levels of metalloproteinase expression. It also outlines a method of treating or preventing these syndromes through the administration of metalloproteinase inhibitors.

Career Highlights

Throughout his career, Chi-Ming Liang has worked with esteemed organizations such as the Wisconsin Alumni Research Foundation and the National Institutes of Health, a component of the US Department of Health & Human Services. His work has had a profound impact on medical research and treatment methodologies.

Collaborations

Chi-Ming Liang has collaborated with notable colleagues, including Nancy A. Turner and Donald T. Witiak. Their combined efforts have contributed to advancements in the medical field.

Conclusion

Chi-Ming Liang's innovative work in the development of monoclonal antibodies and treatment methods for vascular leakage syndrome showcases his dedication to improving medical science. His contributions continue to influence the field and offer hope for better diagnostic and therapeutic options.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…